Best Healthcare Companies in Victoria, Australia
The 369 best Healthcare companies in Victoria, Australia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Mesoblast.
Ranked: Best Healthcare companies in Victoria
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Mesoblast Biotherapeutics derived from proprietary adult stem cell-based technologies | $980M | 17 mo ago | Public | 83 | — | DrupalPHPAmazon Web Services+19 | 70 patents Regenerative cell therapies using adult multipotent stem cells for neurological and musculoskeletal disorders | — |
| 2 | Affinity Health Healthcare organization focused on improving the quality of healthcare services | $667M | 267 mo ago | Acquired | — | — | — | — | — |
| 3 | 4DMedical Manufacturer of respiratory imaging and ventilation analysis equipment | $115M | 4 mo ago | Public | 141 | — | WordPress Block EditorElementorWordPress+27 | 33 patents AI-driven pulmonary imaging and functional assessment for diagnosis and treatment monitoring | — |
| 4 | Paradigm Biopharma Repurposing pentosan polysulphate sodium (PPS) for new orthopaedic and respiratory applications. | $71M | 74 mo ago | Public | — | — | WordPressMySQLPHP+21 | — | 1 launch |
| 5 | Paragon Care Diversified medical devices distributor | $59M | 100 mo ago | Public | 508 | Carmen Riley CEO & Managing Director | DrupalApple iCloud MailMicrosoft 365+22 | — | 9 job openings |
| 6 | Vision Eye Institute Chain of eye care hospitals | $58M | 130 mo ago | Acquired | 201 | — | WordPressMySQLPHP+31 | — | — |
| 7 | Immuron Developer of oral immunotherapy utilizing polyclonal antibody products | $37M | 70 mo ago | Public | 6 | Jerry Kanellos CEO | Cart FunctionalityWooCommerceWordPress+19 | 79 patents Bovine hyperimmune colostrum therapeutics for bacterial and viral gastrointestinal infections | 1 launch |
| 8 | MorphImmune R&D company manufacturing drugs for multiple therapeutic areas | $32M | 37 mo ago | Series B | 11 | Philip Low Founder | — | — | — |
| 9 | Kismet Foundation focused on providing of accessible healthcare services | $24M | 21 mo ago | Seed | 12 | Mark Woodland Co-Founder & CEO | Apple iCloud MailMicrosoft 365Node.js+20 | — | — |
| 10 | Heidi Developer of an AI assistant designed for clinical documentation support 78AI top 20%Tech top 24%Talent top 28%Funding top 30% All 10 signals ▾AItop 20% Techtop 24% Talenttop 28% Fundingtop 30% Customerstop 33% Growthtop 35% Moattop 42% Producttop 46% Marketbottom 45% Globalbottom 38% AI: Classified as an AI company Tech: 59 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 78/100 | $15M | 8 mo ago | Series B | — | Tom Kelly Co-Founder & CEO | SanitySentryApple iCloud Mail+31 | — | — |
| 11 | MCRI Center for research in child health | $12M | 89 mo ago | Series A | 1,266 | David Danks Co-Founder | JoomlaApple iCloud MailPHP+18 | — | — |
| 12 | Planet Innovation Provider of end-to-end healthtech product development and manufacturing services | $10M | 66 mo ago | Series A | 500 | Stuart Elliott Co-Founder & Co-CEO | WordPressMySQLPHP+23 | 10 patents Automated cytopathology sample prep, staining instruments, and AI image analysis | — |
| 13 | Althea Company Producer, supplier, and exporter of pharmaceutical grade medicinal cannabis | $8M | 57 mo ago | Public | 59 | Joshua Fegan CEO & MD | WordPress Block EditorWordPressMySQL+23 | — | — |
| 14 | Atmo Biosciences Swallowable sensors for profiling intestinal gases | $7M | 32 mo ago | Series B | 31 | Malcolm Hebblewhite CEO | — | 21 patents Ingestible capsule sensors for gastrointestinal diagnostics and targeted therapeutic delivery | 1 award |
| 15 | Montu Manufacturer & supplier of cannabinoid products | $6M | 54 mo ago | Series A | 21 | — | Wix eCommerceWixSentry+25 | — | 2 awards |
| 16 | Neo-Bionica Company specializing in the development of medical device prototypes for targeted therapies and diagnostics | $5M | 25 mo ago | Series A | 19 | Ludovic Labat CEO | Framer SitesReactPriority Hints+7 | — | 1 launch |
| 17 | Nutrition Innovation Food production technology company | $5M | 87 mo ago | Series A | 9 | — | — | — | — |
| 18 | MuriGen Therapeutics Australian, early-stage biotech developing anti-apoptotic agents for inflammatory diseases, cancer… | $4M | 232 mo ago | Deadpooled | — | Nick Samaras CEO | — | — | — |
| 19 | More Good Days Provider of pain education and self-management strategy services | $4M | 0 mo ago | Series A | — | Neala Fulia Co-Founder & CEO | WebflowStripeAmazon Web Services+19 | — | 1 job opening |
| 20 | MindBio Therapeutics Provider of phase I & II clinical trial services for mental health diseases | $3M | 2 mo ago | Public | 18 | Justin Hanka Co-Founder & Executive Director (CNSX:MBIO) | Cart FunctionalitySquarespace CommerceSquarespace+12 | — | 4 launchs |
| 21 | Optiscan Confocal Microscopy imaging for clinical applications | $2M | 171 mo ago | Public | 8 | — | Apple iCloud MailZURB FoundationYouTube+15 | — | 1 launch |
| 22 | ANDHealth Association focused on development, commercialization & implementation of digital health technologies | $1M | 43 mo ago | Seed | — | Bronwyn Grice CEO | — | — | — |
| 23 | Apiam Animal Health Provider of veterinary health products | $900K | 50 mo ago | Acquired | — | — | WordPress Block EditorWordPressApple iCloud Mail+24 | — | 1 job opening · 1 expansion · 1 award |
| 24 | Q-Sera Technology to enable blood clotting | $900K | 168 mo ago | Seed | — | Michael Grant CEO | Node.jsBootstrapReact+9 | — | — |
| 25 | Sleeptite Manufacturer of aged monitoring devices | $850K | 56 mo ago | Seed | — | Cameron Dungen CEO | — | — | — |
| 26 | Kite Therapy Early childhood therapy company providing transdisciplinary therapy for children with autism and… | $750K | 25 mo ago | Seed | — | Matt Morrison Co-Founder | — | — | — |
| 27 | ESN Cleer Association focused on manufacturing of medical devices | $700K | 61 mo ago | Seed | 5 | — | — | 6 patents Predictive cardiac failure biomarkers and diagnostic drug‑biomarker combos for heart failure. | — |
| 28 | Lactamo Manufacturer of soft sphere for breastfeeding | $237K | 28 mo ago | Funding Raised | 1 | Etta Watts-Russell Founder | Cart FunctionalityShopifyVisa+21 | — | 1 award |
Top 12 Healthcare companies in Victoria
#1
Public · Melbourne, Victoria · founded 2012 · 141 employees$114.8Mraised▾
Manufacturer of respiratory imaging and ventilation analysis equipment
- Jan 2026Post IPO$100.5M
- Jul 2023Grant (prize money)$740K
- May 2023Post IPO$13.6M
#2
Public · Melbourne, Victoria · founded 2004 · 83 employees$979.8Mraised▾
Mesoblast specializes in developing cellular medicines. The company has a clinically advanced and diverse portfolio of cell-based products with five programs, two of which are partnered, in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2. These clinical programs target therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The Japanese Government has approved TEMCELL® HS. Inj., a product based on their proprietary allogeneic mesenchymal lineage adult stem cell technology licensed to JCR Pharmaceuticals Co. Ltd for the treatment of graft versus host disease in children and adults in Japan. Their product candidate, MSC-100-IV, has orphan drug designation and is being developed under an accelerated regulatory approval pathway in line with the United States Food and Drug Administration (FDA) discussions for children with steroid-refractory acute graft versus host disease. Two other lead product candidates, MPC-150-IM and MPC-06-ID, are in late-stage development in Phase 3 programs targeting, respectively, advanced chronic heart failure and chronic low bac
- Jan 2025Post IPO$160M
- Apr 2023Post IPO—
- Aug 2022Post IPO$45M
- Mar 2021Post IPO$110M
#3
Series A · Carlton, Victoria · founded 2015$3.5Mraised▾
Provider of pain education and self-management strategy services
- Feb 2024Grant (prize money)$257.8K
- Mar 2023Series A$3.5M
#4
Public · Melbourne, Victoria · founded 2021 · 18 employees$3Mraised▾
Provider of phase I & II clinical trial services for mental health diseases
- Apr 2026Post IPO$987.9K
- May 2025Post IPO$66.6K
- Apr 2025Post IPO$1.4M
- Apr 2025Post IPO$111.7K
#5
Series B · Melbourne, Victoria · founded 2019$15Mraised▾
Developer of an AI assistant designed for clinical documentation support. The AI transcribes visits, structures notes, and generates referrals. It also auto-applies codes and tasks, and sends information to electronic health records. The AI adapts to various clinical specialties and settings.
- Oct 2025Series B$65M
- Mar 2025Series A$16.6M
- Oct 2023Series A$10M
- Aug 2021Seed$5M
#6
Seed · Melbourne, Victoria · founded 2023 · 12 employees$24.3Mraised▾
Foundation focused on providing of accessible healthcare services
- Sep 2024Seed$13.5M
- Mar 2024Seed$8.2M
- May 2023Seed$2.7M
#7
Acquired · Melbourne, Victoria · founded 2003$667Mraised▾
Healthcare organization focused on improving the quality of healthcare services
#8
Series B · Melbourne, Victoria · founded 2020 · 11 employees$32.1Mraised▾
R&D company manufacturing drugs for multiple therapeutic areas
- May 2023Series B$15M
- Feb 2022Series B$17.1M
#9
Series A · Melbourne, Victoria · founded 2021 · 19 employees$5Mraised▾
Neo-Bionica is a collaborative initiative between the Bionics Institute and The University of Melbourne, located in St Vincent's Hospital, Melbourne. They specialize in developing medical device prototypes for targeted therapies and diagnostics.
- May 2024Series A$5M
#10
Public · Melbourne, Victoria · founded 2014$70.7Mraised▾
Paradigm Biopharma focussed on repurposing pentosan polysulphate sodium (PPS) for new orthopaedic and respiratory applications. Its lead clinical indications include treating injuries that result in bone marrow edema (BME) and the allergic inflammatory response in allergic rhinitis (AR), which is commonly known as ‘Hay Fever’. Its PPS formulations in development include Zilosul for patients with a BME lesion following an ACL injury (Phase 2); Rhinosul nasal spray for Allergic Rhinitis (Phase 1). The company also has a preclinical program for allergic asthma.
- Apr 2020Post IPO$21.6M
- Apr 2019Post IPO$36.9M
- Dec 2018Post IPO—
- Oct 2018Post IPO$6.4M
#11
Series B · Melbourne, Victoria · founded 2017 · 31 employees$7Mraised▾
Atmo Biosciences is a spinoff of the RMIT University in Melbourne, Australia that is commercializing a swallowable gas sensor that can reliably profile and monitor intestinal gases such as hydrogen, carbon dioxide, oxygen, etc. in real time. The capsule seamlessly transmits the data to a smartphone. Atmo has partnered with Planet Innovation, a product development firm, to develop their technology as a diagnostic device for an array of gut disorders, from food nutrient malabsorption to colon cancer.
- Sep 2023Series B—
- Mar 2023Series B$5.3M
- Jun 2020Seed$1.7M
- Mar 2019Seed—
#12
Public · Carlton, Victoria · founded 1994 · 6 employees$37Mraised▾
Developer of oral immunotherapy utilizing polyclonal antibody products. The product Travelan for traveler's diarrhea is a non-absorbable and safe product that has antibacterial antibodies that work on gut immune system and the gut microbiome and Protectyn that promote digestion and healthy gastrointestinal system health.
- Jul 2020Post IPO$20M
- Feb 2018Post IPO$5.1M
- Jun 2017Conventional Debt$1.5M
- Jul 2016Post IPO$5.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.